Literature DB >> 2624178

Comparative study of thymine and uracil metabolism in healthy persons and in a patient with dihydropyrimidine dehydrogenase deficiency.

A H van Gennip1, N G Abeling, L Elzinga-Zoetekouw, L G Scholten, A van Cruchten, H D Bakker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2624178     DOI： 10.1007/978-1-4684-5673-8_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  Screening for defects of dihydropyrimidine degradation by analysis of amino acids in urine before and after acid hydrolysis.

Authors:  A H van Gennip; P C Driedijk; A Elzinga; N G Abeling
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Dihydropyrimidine dehydrogenase deficiency: a novel mutation and expression of missense mutations in E. coli.

Authors:  P Vreken; A B van Kuilenburg; R Meinsma; F A Beemer; M Duran; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

3.  Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene.

Authors:  P Vreken; A B Van Kuilenburg; R Meinsma; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 4.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency.

Authors:  P Vreken; A B Van Kuilenburg; R Meinsma; G P Smit; H D Bakker; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

6.  Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure.

Authors:  André B P van Kuilenburg; Doreen Dobritzsch; Rutger Meinsma; Janet Haasjes; Hans R Waterham; Malgorzata J M Nowaczyk; George D Maropoulos; Guido Hein; Hermann Kalhoff; Jean M Kirk; Holger Baaske; Anne Aukett; John A Duley; Kate P Ward; Ylva Lindqvist; Albert H van Gennip
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 7.  How may anticancer chemotherapy with fluorouracil be individualised?

Authors:  Su-arpa Ploylearmsaeng; Uwe Fuhr; Alexander Jetter
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

8.  Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs.

Authors:  Saganuwan Alhaji Saganuwan
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-11       Impact factor: 2.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.